These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17367556)

  • 1. The therapeutic potential of gene transfer for the treatment of peripheral neuropathies.
    Goss JR
    Expert Rev Mol Med; 2007 Mar; 9(8):1-20. PubMed ID: 17367556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term neuroprotection achieved with latency-associated promoter-driven herpes simplex virus gene transfer to the peripheral nervous system.
    Chattopadhyay M; Wolfe D; Mata M; Huang S; Glorioso JC; Fink DJ
    Mol Ther; 2005 Aug; 12(2):307-13. PubMed ID: 15927533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of herpes simplex virus-mediated neurotrophin gene transfer in cisplatin neuropathy.
    Chattopadhyay M; Goss J; Wolfe D; Goins WC; Huang S; Glorioso JC; Mata M; Fink DJ
    Brain; 2004 Apr; 127(Pt 4):929-39. PubMed ID: 14749293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth.
    Kirchmair R; Walter DH; Ii M; Rittig K; Tietz AB; Murayama T; Emanueli C; Silver M; Wecker A; Amant C; Schratzberger P; Yoon YS; Weber A; Panagiotou E; Rosen KM; Bahlmann FH; Adelman LS; Weinberg DH; Ropper AH; Isner JM; Losordo DW
    Circulation; 2005 May; 111(20):2662-70. PubMed ID: 15897348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of HSV vectors to modify the nervous system.
    Glorioso JC; Fink DJ
    Curr Opin Drug Discov Devel; 2002 Mar; 5(2):289-95. PubMed ID: 11926135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of recombinant human nerve growth factor (rhNGF) as a treatment for peripheral neuropathic disease.
    Rogers BC
    Neurotoxicology; 1996; 17(3-4):865-70. PubMed ID: 9086510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy applications for the treatment of neuropathic pain.
    Goss JR; Goins WF; Glorioso JC
    Expert Rev Neurother; 2007 May; 7(5):487-506. PubMed ID: 17492900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple myeloma, painful neuropathy, acupuncture?
    Zhou Y; Garcia MK; Chang DZ; Chiang J; Lu J; Yi Q; Romaguera J; Delasalle K; Guo Y; Forman A; Fang W; Wang M
    Am J Clin Oncol; 2009 Jun; 32(3):319-25. PubMed ID: 19887992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for chronic pain.
    Glorioso JC; Mata M; Fink DJ
    Curr Opin Mol Ther; 2003 Oct; 5(5):483-8. PubMed ID: 14601516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective neuropathic pain relief through sciatic nerve administration of GAD65-expressing rAAV2.
    Kim J; Kim SJ; Lee H; Chang JW
    Biochem Biophys Res Commun; 2009 Oct; 388(1):73-8. PubMed ID: 19643087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservative treatment of peripheral neuropathy and neuropathic pain.
    Francis DA; Christopher AT; Beasley BD
    Clin Podiatr Med Surg; 2006 Jul; 23(3):509-30. PubMed ID: 16958385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted delivery of growth factors by HSV-mediated gene transfer for peripheral neuropathy.
    Chattopadhyay M
    Curr Gene Ther; 2013 Oct; 13(5):315-21. PubMed ID: 24369058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of peripheral neuropathies with neutrotrophic factors: animal models and clinical trials].
    Pradat PF
    Rev Neurol (Paris); 2003 Feb; 159(2):147-61. PubMed ID: 12660566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic neuropathy: therapies on the horizon.
    Mahmood D; Singh BK; Akhtar M
    J Pharm Pharmacol; 2009 Sep; 61(9):1137-45. PubMed ID: 19703362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic approach in peripheral neuropathies].
    Léger JM
    Rev Prat; 1992 Jan; 42(1):46-50. PubMed ID: 1314414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo gene therapy for pyridoxine-induced neuropathy by herpes simplex virus-mediated gene transfer of neurotrophin-3.
    Chattopadhyay M; Wolfe D; Huang S; Goss J; Glorioso JC; Mata M; Fink DJ
    Ann Neurol; 2002 Jan; 51(1):19-27. PubMed ID: 11782980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laminin alpha1 chain improves laminin alpha2 chain deficient peripheral neuropathy.
    Gawlik KI; Li JY; Petersén A; Durbeej M
    Hum Mol Genet; 2006 Sep; 15(18):2690-700. PubMed ID: 16893907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental models of peripheral neuropathies.
    Notterpek L; Tolwani RJ
    Lab Anim Sci; 1999 Dec; 49(6):588-99. PubMed ID: 10638493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of AAV vectors in the treatment of metabolic disease.
    Alexander IE; Cunningham SC; Logan GJ; Christodoulou J
    Gene Ther; 2008 Jun; 15(11):831-9. PubMed ID: 18401432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approach to a case of autonomic peripheral neuropathy.
    Chowdhury D; Patel N
    J Assoc Physicians India; 2006 Sep; 54():727-32. PubMed ID: 17212023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.